BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 7786639)

  • 1. Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats.
    Watson P; Lazowski D; Han V; Fraher L; Steer B; Hodsman A
    Bone; 1995 Mar; 16(3):357-65. PubMed ID: 7786639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats.
    Qi H; Li M; Wronski TJ
    J Bone Miner Res; 1995 Jun; 10(6):948-55. PubMed ID: 7572319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.
    Li M; Mosekilde L; Søgaard CH; Thomsen JS; Wronski TJ
    Bone; 1995 Jun; 16(6):629-35. PubMed ID: 7669439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats.
    Iwaniec UT; Moore K; Rivera MF; Myers SE; Vanegas SM; Wronski TJ
    Osteoporos Int; 2007 Mar; 18(3):351-62. PubMed ID: 17120182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
    Zhou H; Shen V; Dempster DW; Lindsay R
    J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.
    Baumann BD; Wronski TJ
    Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
    Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
    J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength--assessed in a sexually mature, ovariectomized rat model.
    Mosekilde L; Danielsen CC; Søgaard CH; McOsker JE; Wronski TJ
    Bone; 1995 Feb; 16(2):223-30. PubMed ID: 7756051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats.
    Wronski TJ; Yen CF; Qi H; Dann LM
    Endocrinology; 1993 Feb; 132(2):823-31. PubMed ID: 8425497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
    Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
    J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.
    Kimmel DB; Bozzato RP; Kronis KA; Coble T; Sindrey D; Kwong P; Recker RR
    Endocrinology; 1993 Apr; 132(4):1577-84. PubMed ID: 8462456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of femoral neck to estrogen depletion and parathyroid hormone in aged rats.
    Li M; Wronski TJ
    Bone; 1995 May; 16(5):551-7. PubMed ID: 7544601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
    Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
    Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V; Birchman R; Wu DD; Lindsay R
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats.
    Turner RT; Evans GL; Cavolina JM; Halloran B; Morey-Holton E
    Endocrinology; 1998 Oct; 139(10):4086-91. PubMed ID: 9751486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone anabolic effects of separate and combined therapy with growth hormone and parathyroid hormone on femoral neck in aged ovariectomized osteopenic rats.
    Wang L; Orhii PB; Banu J; Kalu DN
    Mech Ageing Dev; 2001 Jan; 122(1):89-104. PubMed ID: 11163626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of progesterone on serum levels of IGF-1 and on femur IGF-1 mRNA in ovariectomized rats.
    Barengolts EI; Kouznetsova T; Segalene A; Lathon P; Odvina C; Kukreja SC; Unterman TG
    J Bone Miner Res; 1996 Oct; 11(10):1406-12. PubMed ID: 8889839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.